Bull Run

India's AI-powered stock screener for NSE & BSE. Screen 5,000+ stocks with fundamentals, valuations, and real-time analysis.

info@bullrun.co.in

Navigation

  • Home
  • Smart Screener
  • Stock Battle Arena
  • Watchlist

Tools & Features

  • Advanced Stock Screening
  • Stock Comparison Tool
  • Personal Stock Watchlist
  • Ask AI Assistant
  • Browse All Stocks
  • IPO GMP Tracker
  • Market News & Blog
  • Browse All Sectors
  • Go Premium

Browse Stocks by Sector

180+ sectors listed on NSE & BSE — from Pharmaceuticals to Aerospace & Defence.

View All Sectors
© 2026 Bull Run. All rights reserved.
About UsBlogPrivacy PolicyTerms of Service

Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities. Bull Run is not a SEBI-registered Research Analyst/Investment Adviser.

Financial RatiosPE RatioShareholdingDividendQuarterly ResultsBalance SheetProfit & LossCash Flow
  1. Home
  2. /
  3. Sectors
  4. /
  5. Diversified Commercial Services
  6. /
  7. Sheel Bio.
HomeStocksSheel Bio.

Sheel Bio. Stock Price Today (NSE: SHEEL)

Sheel Bio.

SHEELDiversified Commercial Services
₹80.00+₹0.00 (+0.00%)↑
As on 01 Dec 2025, 04:21 pm ISTMarket Closed

Fundamental Score

...

Sheel Bio. Share Price Live NSE/BSE & Institutional Fundamental Analysis

Sheel Bio. share price today is ₹80.00, up +0.00% on NSE/BSE as of 1 December 2025. Sheel Bio. (SHEEL) is a Small-cap company in the Diversified Commercial Services sector with a market capitalisation of ₹162.82 (Cr). The 52-week high for SHEEL share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 11.34x, SHEEL is currently trading below its industry average P/E of 23.64x. The company has a Return on Equity (ROE) of 13.27% and a debt-to-equity ratio of 0.32.

Sheel Bio. Share Price Chart — NSE/BSE Historical Performance

No data
High
₹0.00
Low
₹0.00
Volume
0
Change
+0.00%

Returns & Performance

Poor

ROE

13.27%
Poor

ROCE

14.48%
Good

OPM (5Y)

11.37%

Div Yield

0.00%

Sheel Bio. Valuation Check

Excellent

P/E Ratio

11.34x
Poor

Industry P/E

23.64x
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Market Cap

162.82 (Cr)

Growth Engine

Excellent

Profit Growth (Q)

105.03%
Excellent

Sales Growth (Q)

93.71%

Sales Growth (5Y)

N/A

EPS Growth (5Y)

N/A

Profit Growth (5Y)

N/A

Balance Sheet Health

Excellent

Debt to Equity

0.32x
Excellent

Int. Coverage

8.07x

Free Cash Flow (5Y)

N/A

Shareholding

Excellent

Promoter

71.26%

FII

N/A

DII

N/A
Excellent

Pledged

0.00%

Institutional Deep-Dive

Bull Run Research Hub

Sheel Bio. Share Price Analysis: A ROCE Efficiency Perspective

The valuation of diversified commercial services companies often hinges on their ability to efficiently deploy capital. Unlike manufacturing, where asset intensity is high, these firms rely on effective resource allocation and strong client relationships. This analysis explores the current state of Sheel Bio. share price, presently trading at ₹80.0, through the lens of Return on Capital Employed (ROCE). Our focus will be on how effectively Sheel Bio. utilizes its capital to generate profits.

Sheel Bio.'s current Price-to-Earnings (PE) ratio stands at 11.34. While PE offers a snapshot of valuation relative to earnings, it's the underlying efficiency that determines long-term sustainability. The company's ROCE of 14.48% is a critical metric. This indicates that for every ₹100 of capital employed, Sheel Bio. generates ₹14.48 in profit. A higher ROCE often signifies a stronger competitive advantage and the potential for reinvesting profits for future growth. This level of ROCE directly impacts the company's "moat" or its ability to defend its market position. Consistent, high ROCE makes it difficult for competitors to erode Sheel Bio.'s profitability.

Comparing Sheel Bio. to its sector peers offers valuable context. While a comprehensive financial audit would require a deeper dive, we can observe that companies like Nirmitee Robotics India Ltd may exhibit different management approaches to capital allocation. Examining their strategic choices and resulting ROCE figures could provide insights into Sheel Bio.'s relative performance and potential for improvement. Factors such as the quality of management decisions significantly influence how effectively a company utilizes its resources. A company's ROCE can be an indicator of management's quality over time.

This analysis is part of a broader, 80-parameter fundamental audit verified by Sweta Mishra, and is intended for informational purposes only. It focuses on observational data and avoids making any buy or sell recommendations regarding Sheel Bio.'s share price. Further investigation into Sheel Bio.'s debt levels, operating margins, and specific capital allocation strategies is recommended for a more comprehensive understanding.

SM
Analysis by Sweta Mishra
SEBI Registered Research Analyst

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Sheel Bio. Fundamental Analysis & Valuation Benchmarking

Educational evaluation of SHEEL across key market metrics for learning purposes.

Positive Indicators

6 factors identified

Attractive Valuation (P/E: 11.34 vs Industry: 23.64)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Robust Profit Growth (105.03%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (93.71%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Strong Interest Coverage (8.07x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Balanced Promoter Holding (71.26%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

1 factors identified

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Sheel Bio. Financial Statements

Comprehensive financial data for Sheel Bio. including income statement, balance sheet and cash flow

About SHEEL (Sheel Bio.)

Sheel Bio. (SHEEL) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Diversified Commercial Services sector with a current market capitalisation of ₹162.82 (Cr). Sheel Bio. has delivered a Return on Equity (ROE) of 13.27% and a ROCE of 14.48%. The debt-to-equity ratio stands at 0.32, reflecting the company's capital structure. Investors tracking SHEEL share price can monitor key metrics including P/E ratio, promoter holding of 71.26%, and quarterly earnings growth.

Company Details

Symbol:SHEEL
Industry:Diversified Commercial Services
Sector:N/A
Website:N/A

SHEEL Share Price: Frequently Asked Questions

What is the current share price of Sheel Bio. (SHEEL)?

As of 01 Dec 2025, 04:21 pm IST, Sheel Bio. share price is ₹80.00. The SHEEL stock has a market capitalisation of ₹162.82 (Cr) on NSE/BSE.

Is SHEEL share price Overvalued or Undervalued?

SHEEL share price is currently trading at a P/E ratio of 11.34x, compared to the industry average of 23.64x. Based on this relative valuation, the Sheel Bio. stock appears to be Undervalued against its sector peers.

What is the 52-week high and low of SHEEL share price?

The 52-week high of SHEEL share price is ₹N/A and the 52-week low is ₹N/A.

What factors affect the Sheel Bio. share price?

Key factors influencing SHEEL share price include quarterly earnings growth (Sales Growth: 93.71%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Sheel Bio. a good stock for long-term investment?

Sheel Bio. shows a 5-year Profit Growth of N/A% and an ROE of 13.27%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.32 before investing in SHEEL shares.

How does Sheel Bio. compare with its industry peers?

Sheel Bio. competes with major peers in the Diversified Commercial Services. Investors should compare SHEEL share price P/E of 11.34x and ROE of 13.27% against the industry averages to determine competitive standing.

What is the P/E ratio of SHEEL and what does it mean?

SHEEL share price has a P/E ratio of 11.34x compared to the industry average of 23.64x. Investors pay ₹11 for every ₹1 of annual earnings.

How is SHEEL performing according to Bull Run's analysis?

SHEEL has a Bull Run fundamental score of 49/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.

What sector and industry does SHEEL belong to?

SHEEL operates in the Diversified Commercial Services industry. This classification helps understand the competitive landscape and sector-specific trends affecting Sheel Bio. share price.

What is Return on Equity (ROE) and why is it important for SHEEL?

SHEEL has an ROE of 13.27%, which shows decent profitability but room for improvement. ROE measures how efficiently Sheel Bio. generates profits from shareholders capital.

How is SHEEL debt-to-equity ratio and what does it indicate?

SHEEL has a debt-to-equity ratio of 0.32, which indicates moderate leverage that should be monitored.

What is SHEEL dividend yield and is it a good dividend stock?

SHEEL offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Sheel Bio. shares.

How has SHEEL share price grown over the past 5 years?

SHEEL has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.

What is the promoter holding in SHEEL and why does it matter?

Promoters hold 71.26% of SHEEL shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Sheel Bio..

What is SHEEL market capitalisation category?

SHEEL has a market capitalisation of ₹163 crores, placing it in the Small-cap category.

How volatile is SHEEL stock?

SHEEL has a beta of N/A. A beta > 1 suggests the Sheel Bio. stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is SHEEL operating profit margin trend?

SHEEL has a 5-year average Operating Profit Margin (OPM) of 11.37%, indicating the company's operational efficiency.

How is SHEEL quarterly performance?

Recent quarterly performance shows Sheel Bio. YoY Sales Growth of 93.71% and YoY Profit Growth of 105.03%.

What is the institutional holding pattern in SHEEL?

SHEEL has FII holding of N/A% and DII holding of N/A%. Significant institutional holding often suggests professional confidence in the Sheel Bio. stock.

HomeScreenerBattleWatchlist

Frequently Asked Questions about Sheel Bio.

What is the current share price of Sheel Bio.?

Sheel Bio. (SHEEL) is currently trading at ₹80.00 per share on NSE. Sheel Bio. is a Small-cap company with a market capitalisation of ₹162.82 (Cr). Prices are updated daily. This is for educational purposes only and does not constitute investment advice.

What is the P/E ratio of Sheel Bio.?

Sheel Bio. (SHEEL) has a Price-to-Earnings (P/E) ratio of 11.34x. This ratio indicates how much investors are paying for every rupee of earnings. A lower P/E compared to the industry average may indicate undervaluation. This is informational data only.

What is the market capitalisation of Sheel Bio.?

Sheel Bio. has a market capitalisation of ₹162.82 (Cr), classifying it as a Small-cap stock. Market cap is calculated as current share price × total outstanding shares and is used for peer group comparisons.

What is the Bull Run score for Sheel Bio.?

Sheel Bio. has a Bull Run fundamental score of 49/100. This AI-generated score evaluates the stock across 25+ parameters including profitability, growth, debt levels, and valuations. A higher score indicates stronger fundamentals.

Does Sheel Bio. pay dividends?

Sheel Bio. has a dividend yield of 0.00%. Dividend yield shows annual dividend income as a percentage of the current share price. This is historical data and future dividends are not guaranteed.

What is the ROE of Sheel Bio.?

Sheel Bio. has a Return on Equity (ROE) of 13.27%. ROE measures how effectively a company uses shareholder equity to generate profits. A higher ROE generally indicates better management efficiency.

What is the debt-to-equity ratio of Sheel Bio.?

Sheel Bio. has a debt-to-equity ratio of 0.32. A lower ratio generally indicates lower financial risk. This metric helps assess how much of the company's operations are funded by debt versus shareholder equity.

How does Sheel Bio. compare to other Diversified Commercial Services sector stocks?

Sheel Bio. operates in the Diversified Commercial Services sector in India. With a P/E of 11.34x and ROE of 13.27%, you can compare it with peers in the same sector using Bull Run's stock screener. Use the sector page to view all Diversified Commercial Services companies ranked by fundamentals.

Where can I buy Sheel Bio. shares?

Sheel Bio. shares are listed on NSE and can be purchased through any SEBI-registered stockbroker in India. You will need a demat account and trading account. Popular brokers include Zerodha, Upstox, Angel One, and ICICI Direct. Bull Run does not offer brokerage services.

Is Sheel Bio. a good investment?

Bull Run provides data-driven fundamental scores for Sheel Bio. to help you research the stock. The composite score of 49/100 is based on financials including P/E 11.34x, ROE 13.27%, and debt-to-equity 0.32. Bull Run is not a SEBI-registered advisor — this is not investment advice. Please consult a financial advisor before investing.